|
|||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
Parents from Essex have won their case after making a compensation claim for clinical negligence on behalf of their 27-year-old son, who died during a drugs trial in 2007.
The trials in which the man was participating were for a drug which was meant to one day help testicular cancer sufferers survive the disease. The tests were being undertaken at University College London Hospital (UCLH) but, due to input errors on the NHS Trust's system, and the failure of medical staff to notice the victim's deterioration, he did not survive treatment.
The young man was given a double dose of the prescribed chemotherapy drugs, on seven different occasions, and, as a result, he suffered lung failure.
The electronic system on the hospital computers, which was used to prescribe the drugs being used during the treatment, had been set up incorrectly. Furthermore, the professionals in charge of the research did not notice the failing health of the victim. The trial was government funded, but, since it was taking place at UCLH, the hospital was found liable for the mistakes made.
Described in a statement from UCLH as "an accidental healthcare event," it paid around £300,000 to the family as a settlement for the clinical negligence claim, and has taken steps towards avoiding a re-occurrence of the unfortunate incident in future trials.
|
|||||||||||||||||||||||||||||||||||||||||||||
